ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Current Covid variants are mild: Serum CEO Adar Poonawala

Current Covid variants are mild: Serum CEO Adar Poonawala

While addressing the mediapersons in Pune, Adar Poonawala said, "We have produced 5-6 million doses as stock,...

      
      NTAGI holds meet on Covovax inclusion as heterologous booster

NTAGI holds meet on Covovax inclusion as heterologous booster

National Technical Advisory Group on Immunisation conducted a meeting on February 8 regarding the inclusion of...

      
      China needs good Covid 19 booster like Covovax: Adar Poonawala

China needs good Covid 19 booster like Covovax: Adar Poonawala

China needs a good Covid 19 booster vaccine like Covovax, but so far there hasn't been a positive response from...


      
      NTAGI to discuss inclusion of Covovax in CoWIN portal

NTAGI to discuss inclusion of Covovax in CoWIN portal

The National Technical Advisory Group on Immunisation (NTAGI) is likely to meet soon to discuss inclusion of...


      
      DGCI approves market authorisation of Covovax as booster dose

DGCI approves market authorisation of Covovax as booster dose

This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin.

      
      DCGI recommends Covovax as heterologous booster dose

DCGI recommends Covovax as heterologous booster dose

The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market...


      
      India logs 170 cases of Covid 19 in last 24 hours

India logs 170 cases of Covid 19 in last 24 hours

India has recorded 170 new cases of Covid-19 in the last 24 hours, the Union Ministry of Health and Family Welfare...

      
      Covovax to get booster dose approval in 10-15 days: SII CEO

Covovax to get booster dose approval in 10-15 days: SII CEO

Serum Institute of India CEO Adar Poonawalla on Monday said that the Covovax vaccine will get approval as a booster...

      
      SII stopped production of Covishield vaccine since December 2021

SII stopped production of Covishield vaccine since December 2021

Pune (Maharashtra) [India], October 20 (ANI): Chief Executive Officer of Serum Institute of India (SII), Adar...

      
      SII's Covovax gets emergency use nod for 7-12 years

SII's Covovax gets emergency use nod for 7-12 years

New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has given restricted emergency use...

      
      'COVID vaccine Covovax available for above 12 years age group'

'COVID vaccine Covovax available for above 12 years age group'

Pune (Maharashtra) [India], May 5 (ANI): Chief Executive Officer of Pune based Serum Institute of India Adar...

      
      COVID-19 vaccine Covovax now available for children in India

COVID-19 vaccine Covovax now available for children in India

New Delhi [India], May 3 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the COVID-19...
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.